FX−/− mice develop a myeloproliferative disorder. (A) FACS analysis of the percentage of granulocytes (Gr-1
+), B lymphocytes (B220
+), and erythrocytes (TER119
+) in the bone marrow in 3- to 4-month-old control mice (WT; n = 8), FX
−/− mice reared on fucose-supplemented chow until 12 weeks of age, and then on standard chow for at least 4 weeks (n = 8; FX
−/−, no fucose), and FX
−/− mice reared on fucose-supplemented chow until use (n = 8; FX
−/−, with fucose). (B) May-Grünwald-Giemsa–stained cytospins of marrow cells showing increased segmented neutrophils (

) and myeloid progenitor cells (

) in the bone marrow of FX
−/− mice (no fucose). (C) Differential blood counts on May-Grünwald-Giemsa–stained cytospins of marrow cells showing percentage of myeloid progenitor cells at various developmental stage and mature neutrophils (WT, n = 8; FX
−/−, no fucose, n = 9; FX
−/−, with fucose, n = 9). (D,E) FACS analysis of bone marrow myeloid progenitors (CMP: Lin
−c-kit
+Sca-1
−IL7R
−CD34
+FcγRII
low; GMP: Lin
−c-kit
+Sca-1
−IL7R
−CD34
+FcγRII
+; MEP: Lin
−c-kit
+Sca-1
−IL7R
−CD34
lowFcγRII
low). (F) FACS analysis of CLP compartment (Lin
−c-kit
lowSca-1
lowIL7R
+). Bar graphs represent the average total number of CLP cells (± SD) from 2 tibias and 2 femurs of each mouse.